John Stanley
Family Medicine · Kansas City, MONPI 1457358459
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,066 and has fallen 70.9% since, to $311 in 2021.
Across 147 payments — averaging $13.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$327
- Amarin Pharma, Inc.$252
- Pfizer$237
- Amgen$225
- Novo Nordisk$206
- Johnson & Johnson$163
- plus $629 from 22 others
What the payments were for
- Food & beverage$2,039100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $327 |
| Amarin Pharma, Inc. | 21 | $252 |
| Pfizer | 22 | $237 |
| Amgen | 17 | $225 |
| Novo Nordisk | 19 | $206 |
| Johnson & Johnson | 9 | $163 |
| AbbVie(2 entities) | 6 | $93 |
| Astellas Pharma US Inc | 4 | $68 |
| Novartis | 4 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| GSK | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Merck | 3 | $37 |
| Boehringer Ingelheim | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Roche Diagnostics Corporation | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Aytu Biopharma, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,039 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Kansas City
- Blair ThedingerKansas City$71K
- Jon MattsonKansas City$53K
- Meredith LevineKansas City$26K
- Kelly SandriKansas City$17K
- Michael SimanovskyKansas City$16K
- Teresa MarshallKansas City$16K
- Nora GomezKansas City$15K
- Julie AlvarezKansas City$15K
- Neal MooreKansas City$14K
- Stephen AdamsSpringfield$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.